Gibson v. American Cyanamid Co

CourtDistrict Court, E.D. Wisconsin
DecidedMarch 22, 2021
Docket2:07-cv-00864
StatusUnknown

This text of Gibson v. American Cyanamid Co (Gibson v. American Cyanamid Co) is published on Counsel Stack Legal Research, covering District Court, E.D. Wisconsin primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Gibson v. American Cyanamid Co, (E.D. Wis. 2021).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF WISCONSIN

GLENN BURTON, JR, Plaintiff, v. Case No. 07-CV-0303

AMERICAN CYANAMID CO, et al., Defendants;

RAVON OWENS, Plaintiff, v. Case No. 07-CV-0441

CESAR SIFUENTES, Plaintiff, v. Case No. 10-CV-0075

AMERICAN CYANAMID CO, et al., Defendants.

MANIYA ALLEN, et al., Plaintiffs, v. Case No. 11-CV-0055

ERNEST GIBSON, Plaintiff, v. Case No. 07-CV-0864

DIJONAE TRAMMELL, Plaintiff, v. Case No. 14-CV-1423

AMERICAN CYANAMID CO, et al., Defendants DEZIREE VALOE and DETAREION VALOE Plaintiffs, v. Case No. 11-CV-0425

AMERICAN CYANAMID CO, et al.,

DECISION AND ORDER

The Sherwin-Williams Company is one of several defendants in lawsuits brought by approximately 170 plaintiffs under Wisconsin’s risk contribution theory of tort liability. The plaintiffs allege that they suffered personal injuries as a result of ingesting white lead carbonate pigment that was present in the paint used on their childhood homes. The lawsuits were assigned to me. In May 2019, three of them went to trial, and the jury found Sherwin Williams and two other defendants liable to the plaintiffs. After judgment was entered, the defendants appealed, and those appeals are pending in the United States Court of Appeals for the Seventh Circuit. Another group of four cases are in the final stages of preparation for a consolidated trial, though the trial date is uncertain because of the COVID-19 pandemic. In each case, Sherwin-Williams has filed a motion arguing that I must disqualify myself under 28 U.S.C. § 455(a).1

1 Sherwin-Williams filed its motion using a caption that includes the three cases that are on appeal. It is not clear why Sherwin-Williams seeks to disqualify me from those cases at this time. Proceedings in the district court have ended, and while there is a possibility of a remand for further proceedings, such a remand may never occur. Although a party may seek relief from a judgment or order under Federal Rule of Civil Procedure 60(b)(6) on the ground that the district judge should have recused, see Liljeberg v. Health Services Acquisition Corp., 486 U.S. 847, 863–64 (1988), Sherwin-Williams does not explicitly move to vacate the judgments entered in the cases that are on appeal. Moreover, while the appeals are pending, I would lack jurisdiction to grant relief under Rule 60(b). See, e.g., Boyko v. Anderson, 185 F.3d 672, 674 (7th Cir. 1999). In any event, because I am denying Sherwin-Williams’ motion as it applies to the cases that remain pending before me, I will also deny the motion as it applies to the cases on appeal. To the extent the motion should be construed as a motion to vacate the judgments entered in those cases, Sherwin-Williams has also filed a motion for leave to file a supplemental memorandum of authority in support of its motion to disqualify. I will grant that motion and consider the supplemental memorandum in addressing the motion to disqualify. I. BACKGROUND

The Wisconsin Supreme Court adopted the risk contribution theory to open a path to recovery for plaintiffs injured by a fungible product who cannot identify the manufacturer of the specific product that caused them harm. The theory was developed in a case involving the drug DES, which was prescribed to pregnant mothers in the mid-twentieth century to prevent miscarriages but was found to cause vaginal cancer in daughters born to those mothers. Collins v. Eli Lilly Co., 116 Wis.2d 166 (1984). The Wisconsin Supreme Court extended the risk contribution theory to white lead carbonate cases in Thomas ex rel. Gramling v. Mallett, 285 Wis.2d 236 (2005). Other than the Thomas case itself, the three cases tried in May 2019 were the first white lead carbonate risk contribution cases to go to trial.

Sherwin-Williams’ motion to disqualify centers on a law review article I authored, in which I contend that economic and political developments in recent decades have eroded America’s democratic institutions and that the decisions of the Roberts Court have contributed to this phenomenon. See Lynn Adelman, The Roberts Court’s Assault on Democracy, 14 Harv. L. & Pol’y Rev. 131 (2019). In one part of the article, I critiqued recent Supreme Court decisions in the area of corporate political speech, which I argue have wrongly construed campaign finance regulations “not as reasonable efforts to

I note that I may deny the motion even though an appeal is pending. See Fed. R. Civ. P. 62.1(a)(2). equalize the political influence of different classes of Americans, but as efforts to censor the voices of the wealthy.” Id. at 149. I also critiqued the Supreme Court’s decision in Sorrell v. IMS Health Inc., 564 U.S. 552 (2011), which involved a Vermont statute that prohibited pharmacies from selling

prescription data to pharmaceutical researchers without affirmative consent from prescribing physicians. I expressed disagreement with the Court’s classification of data- selling as “speech” that was not subject to regulation by a democratically elected legislature. Adelman, supra, at 150-151. I also noted that in previous eras the Court had “connected the protection of commercial speech to the formation of intelligent opinion and to the value of democracy,” but that that connection was not present in Sorrell. Id. at 151. The article also discussed challenges facing the American working class and the poor. It analyzed Supreme Court decisions in which, I argued, the Court had given insufficient weight to these challenges and had in consequence stymied legislative efforts to address them. I argued that the Court’s decisions in this area weakened democracy by

“consistently augment[ing] the power of corporations and the wealthy and reduc[ing] that of ordinary Americans.” Id. at 148. Finally, the article included comments on President Trump and the Republican Party. I wrote that Congressional Republicans “depend on a relatively small number of wealthy donors to stay in power,” and that therefore their policy agenda is determined by the interests of those wealthy donors. Id. at 136. I also wrote that President Trump “is disinclined to buck the wealthy individuals and corporations who control his party.” Id. at 137. After I published this article, members of the public filed three Judicial Conduct Complaints under the Judicial Conduct and Disability Act, asserting that the publication of the article amounted to judicial misconduct because it exhibited disrespect for the judicial system and political bias. The Judicial Council of the Seventh Circuit reviewed

and resolved the complaints. No. 07-CV-0303, ECF No. 1812-2. It determined that my criticisms of Supreme Court decisions (which constitute the majority of the article) are “well within the boundaries of appropriate discourse” and noted that they are largely drawn from the dissenting opinions of Justices in those decisions. Id. at 9-10. It found, however, that the “attacks on Republican party positions could be interpreted . . . as calling into question [my] impartiality in matters implicating partisan or ideological concerns.” Id. at 10. It issued a public admonition, and I made a public statement specifically apologizing for using language that might be construed as expressing bias against the Republican Party and affirming my commitment to the impartial administration of justice in all cases. Id. at 12.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Laird v. Tatum
408 U.S. 1 (Supreme Court, 1972)
Liljeberg v. Health Services Acquisition Corp.
486 U.S. 847 (Supreme Court, 1988)
Liteky v. United States
510 U.S. 540 (Supreme Court, 1994)
In Re Sherwin-Williams Co.
607 F.3d 474 (Seventh Circuit, 2010)
United States v. Microsoft Corp.
253 F.3d 34 (D.C. Circuit, 2001)
United States v. Karl J. Bray
546 F.2d 851 (Tenth Circuit, 1976)
Nicodemus v. Chrysler Corp.
596 F.2d 152 (Sixth Circuit, 1979)
United States v. Joseph Conforte and Sally Conforte
624 F.2d 869 (Ninth Circuit, 1980)
In the Matter of Bradford Mason
916 F.2d 384 (Seventh Circuit, 1990)
Rodney L. Boyko v. Ron Anderson, Superintendent
185 F.3d 672 (Seventh Circuit, 1999)
In Re: Boston's Children First
244 F.3d 164 (First Circuit, 2001)
Collins v. Eli Lilly & Co.
342 N.W.2d 37 (Wisconsin Supreme Court, 1984)

Cite This Page — Counsel Stack

Bluebook (online)
Gibson v. American Cyanamid Co, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gibson-v-american-cyanamid-co-wied-2021.